Product Information
DEPAKOTE DR 500 MG TABLET is a brand product labeled by AbbVie Inc., priced at $7.4534 per EA under NDC 00074732713. Its NADAC has been published 211 times since Jun 8, 2022.
FDA first approved this application on Mar 10, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Divalproex Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
AbbVie Inc.NDC
00074732713
Classification
Brand
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA018723FDA Approved
3/10/1983
TE Code
AB
On Market Since
3/10/1983
Pharmacological Classes
Price Statistics
The NADAC for DEPAKOTE DR 500 MG TABLET has been published 211 times since Jun 8, 2022, and over the history we have for it it has risen 21.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4534 per EA |
|---|---|
| All-time high | $7.4682 (May 13, 2026) |
| All-time low | $6.1481 (Nov 23, 2022) |
| 52-week high | $7.4682 |
| 52-week low | $7.1125 |
| Median price | $6.7849 |
| Average price | $6.8268 |
| Largest weekly change | +5.0% (Jan 11, 2023) |
| Weeks tracked | 211 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEPAKOTE DR 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEPAKOTE DR 500 MG TABLET, manufactured by AbbVie Inc., is $7.4534 per EA (NDC 00074732713), effective Aug 19, 2026.
How has the price of DEPAKOTE DR 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEPAKOTE DR 500 MG TABLET has risen 21.0%. It has been tracked across 211 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for DEPAKOTE DR 500 MG TABLET?
Since Jun 8, 2022, the NADAC for DEPAKOTE DR 500 MG TABLET has ranged from a low of $6.1481 (Nov 23, 2022) to a high of $7.4682 (May 13, 2026), with a median of $6.7849 per EA.
Are there cheaper alternatives to DEPAKOTE DR 500 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIVALPROEX SOD DR 500 MG TAB, is $0.1228 per EA — about 98% below DEPAKOTE DR 500 MG TABLET.
Who manufactures DEPAKOTE DR 500 MG TABLET?
DEPAKOTE DR 500 MG TABLET (NDC 00074732713) is labeled by AbbVie Inc., and CMS classifies it as a brand product.